Sri Monashi Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.22 Cr
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.37 Cr
- Satisfied Charges ₹ 1.95 Cr
- Revenue Growth -32.31%
- Profit Growth -1119.53%
- Ebitda -221.42%
- Net Worth -97.40%
- Total Assets -23.55%
About Sri Monashi Life Sciences
Sri Monashi Life Sciences Private Limited (SMLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 November 2011 and has a history of 13 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.22 Cr.
The company currently has active open charges totaling ₹12.37 Cr. The company has closed loans amounting to ₹1.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sivaram Golla and Veerla Rao serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100TG2011PTC077437
- Company No.
077437
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Sri Monashi Life Sciences Private Limited offer?
Sri Monashi Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Sri Monashi Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivaram Golla  | Director | 15-Nov-2011 | Current |
| Veerla Rao | Director | 22-May-2023 | Current |
Financial Performance of Sri Monashi Life Sciences.
Sri Monashi Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.31% decrease. The company also saw a substantial fall in profitability, with a 1119.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 97.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Monashi Life Sciences?
In 2023, Sri Monashi Life Sciences had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Karthikeya Bio & Pharma Projects Private LimitedSivaram Golla and Veerla Rao are mutual person
- Panaxin Pharmaceuticals Private Limited
Veerla Rao is a mutual person
Charges (Loans)
₹12.37 Cr
₹1.95 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 12.19 Cr
- Axis Bank Limited : 0.12 Cr
- Others : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2021 | Others | ₹0.64 M | Open |
| 23 Mar 2021 | Hdfc Bank Limited | ₹2.07 M | Open |
| 16 Sep 2020 | Axis Bank Limited | ₹1.20 M | Open |
| 31 Aug 2018 | Hdfc Bank Limited | ₹11.98 Cr | Open |
| 02 Mar 2013 | The Karur Vysya Bank Limited | ₹2.50 M | Satisfied |
How Many Employees Work at Sri Monashi Life Sciences?
Sri Monashi Life Sciences has a workforce of 34 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Monashi Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Monashi Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
